Dear Family and Friends,
Greetings! We are pleased to inform you of our transition of kidney health supplement Renadyl to a Live Biotherapeutic Product (LBP) drug category for medical reimbursement reasons. This improved version is known as US APR-2020.
Excellent and Unique Opportunity! US FDA/CBER Approved RCT To Delay Dialysis with Probiotics US-APR 2020 Phase 2B, Multi-site CKD Stage 4 (N=630) Oral and Safe Intestinal Dialysis
In this regard, if you or your friends are interested in exploring the opportunity to be a participant, in this unique clinical trial, please contact the Medical Director at email@example.com.
Are you interested in knowing more information?
Clinical Trial To Evaluate Safety And Efficacy Of US-APR2020 In Subjects With Chronic Kidney Disease Stage IV (CKD), for study details,please click to review: